National Cancer Institute, Naples: all 113 studies
Page 2 of 2. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.
- HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.Active, not recruitingNCT00412022Phase 3
- MITO-6: Capecitabine in Platinum Resistant Ovarian CancerCompletedNCT00403429Phase 2
- MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian CancerCompletedNCT00401674Phase 2
- END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal DoxorubicinCompletedNCT00401635Phase 2
- G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly PatientsCompletedNCT00401609Phase 1/2
- MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung CancerCompletedNCT00401492Phase 2
- HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast CancerCompletedNCT00401427Phase 2
- Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLCCompletedNCT00385606Phase 2/3
- TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerCompletedNCT00349219Phase 3
- The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung CancerTerminatedNCT00345059Phase 3
- ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant TreatmentCompletedNCT00331097Phase 3
- CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung CancerCompletedNCT00330746Phase 2
- MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian CancerStatus unknownNCT00326456Phase 3
← National Cancer Institute, Naples overview and focus areas